{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:02:12Z","timestamp":1790197332688,"version":"4.1.0"},"reference-count":213,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032579","name":"Beijing Medical Award Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Breast cancer is the most common malignancy in women and a major cause of cancer-related mortality. While early-stage disease is often curable, many patients ultimately develop distant metastases, with the brain representing one of the most devastating sites. Breast cancer brain metastasis (BCBM) is particularly prevalent in human epidermal growth factor receptor 2 (HER2)-positive and triple-negative subtypes, leading to severe neurological symptoms, diminished quality of life, and poor prognosis. Despite progress in systemic therapy for primary tumors, outcomes for patients with BCBM remain poor, and these patients are frequently excluded from clinical trials. The pathogenesis of BCBM involves complex interactions between tumor cells and the central nervous system microenvironment. Crossing the blood-brain barrier and adapting to the brain niche requires tumor-stroma crosstalk, including signaling with astrocytes and microglia, which promotes immune evasion, therapeutic resistance, and metastatic outgrowth. Although advances in preclinical models and molecular profiling have provided valuable insights, critical mechanisms remain incompletely understood. Systemic therapies are increasingly important, with HER2-targeted agents, tyrosine kinase inhibitors, and subtype-specific regimens showing activity. Novel approaches, including poly (ADP-ribose) polymerase inhibitors, cyclin-dependent kinase 4\/6 inhibitors, phosphatidylinositol 3-kinase inhibitors, and antibody-drug conjugates, are under evaluation. This review synthesizes epidemiology, molecular mechanisms, and emerging therapies of BCBM, underscoring advances achieved and highlighting the urgent need for novel targeted strategies and inclusive clinical trials.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1801614","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:38:03Z","timestamp":1774593483000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Breast cancer brain metastasis: from molecular insights to therapeutic innovation"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaoxi","family":"Han","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01175-y","article-title":"Treatment strategies for breast cancer brain metastases","volume":"124","author":"Bailleux","year":"2021","journal-title":"Br J Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-1140-x","article-title":"MicroRNAs orchestrate pathophysiology of breast cancer brain metastasis: advances in therapy","volume":"19","author":"Kanchan","year":"2020","journal-title":"Mol Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/jci91553","article-title":"JAK2-binding long noncoding RNA promotes breast cancer brain metastasis","volume":"127","author":"Wang","year":"2017","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70020","article-title":"Metastatic brain tumors: from development to cutting-edge treatment","volume":"6","author":"Tanzhu","year":"2025","journal-title":"MedComm"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/op.23.00794","article-title":"Breast cancer brain metastasis: a comprehensive review","volume":"20","author":"Raghavendra","year":"2024","journal-title":"JCO Oncol Pract"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5021","article-title":"Breast cancer brain metastasis: current evidence and future directions","volume":"12","author":"Sun","year":"2023","journal-title":"Cancer Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01424-8","article-title":"Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies","volume":"125","author":"Wang","year":"2021","journal-title":"Br J Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-01983-4","article-title":"Biological profile of breast cancer brain metastasis","volume":"13","author":"Liu","year":"2025","journal-title":"Acta Neuropathol Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-13-0790","article-title":"CNS metastases in breast cancer: old challenge, new frontiers","volume":"19","author":"Lin","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2004.01.175","article-title":"CNS metastases in breast cancer","volume":"22","author":"Lin","year":"2004","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.38.0527","article-title":"Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases","volume":"30","author":"Sperduto","year":"2012","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.02.027","article-title":"Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases","volume":"82","author":"Sperduto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.breast.2017.10.006","article-title":"External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: a multicentric European experience","volume":"37","author":"Griguolo","year":"2018","journal-title":"Breast"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25746","article-title":"The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases","volume":"117","author":"Anders","year":"2011","journal-title":"Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nos152","article-title":"Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data","volume":"14","author":"Davis","year":"2012","journal-title":"Neuro Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31336","article-title":"Development of CNS metastases and survival in patients with inflammatory breast cancer","volume":"124","author":"Uemura","year":"2018","journal-title":"Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.642677","article-title":"NCCBM, a nomogram prognostic model in breast cancer patients with brain metastasis","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.04.262","article-title":"Nomogram-predicted survival of breast cancer brain metastasis: a SEER-based population study","volume":"128","author":"Xiong","year":"2019","journal-title":"World Neurosurg"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2009.24.6314","article-title":"Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer","volume":"28","author":"Graesslin","year":"2010","journal-title":"J Clin Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl064","article-title":"Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)","volume":"17","author":"Pestalozzi","year":"2006","journal-title":"Ann Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-18-2366","article-title":"Central nervous system metastasis in patients with HER2-positive metastatic breast cancer: patient characteristics, treatment, and survival from SystHERs","volume":"25","author":"Hurvitz","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000006428","article-title":"Infiltration of common myeloid progenitor (CMP) cells is associated with less aggressive tumor biology, lower risk of brain metastasis, better response to immunotherapy, and higher patient survival in breast cancer","volume":"280","author":"Oshi","year":"2024","journal-title":"Ann Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41523-022-00407-z","article-title":"Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer","volume":"8","author":"Garber","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-014-3090-8","article-title":"Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis","volume":"147","author":"Niikura","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.01255","article-title":"Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient","volume":"38","author":"Sperduto","year":"2020","journal-title":"J Clin Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.12.001","article-title":"EMT transition states during tumor progression and metastasis","volume":"29","author":"Pastushenko","year":"2019","journal-title":"Trends Cell Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.768","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-\u03b2 signalling","volume":"110","author":"Yu","year":"2014","journal-title":"Br J Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.08.013","article-title":"Dependency of colorectal cancer on a TGF-\u03b2-driven program in stromal cells for metastasis initiation","volume":"22","author":"Calon","year":"2012","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1158\/1541-7786.mcr-13-0535","article-title":"Insidious changes in stromal matrix fuel cancer progression","volume":"12","author":"Miles","year":"2014","journal-title":"Mol Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.02.006","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by IDH3\u03b1 downregulation","volume":"10","author":"Zhang","year":"2015","journal-title":"Cell Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4161\/cc.21384","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by TGF-\u03b2 drives tumor growth: connecting TGF-\u03b2 signaling with \"Warburg-like\" cancer metabolism and L-lactate production","volume":"11","author":"Guido","year":"2012","journal-title":"Cell Cycle"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju136","article-title":"Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer","volume":"106","author":"Rohan","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.377","article-title":"Macrophage contact induces RhoA GTPase signaling to trigger tumor cell intravasation","volume":"33","author":"Roh-Johnson","year":"2014","journal-title":"Oncogene"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.01.007","article-title":"Macrophages: obligate partners for tumor cell migration, invasion, and metastasis","volume":"124","author":"Condeelis","year":"2006","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41523-017-0008-8","article-title":"Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12","volume":"3","author":"Chung","year":"2017","journal-title":"NPJ Breast Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1016234107","article-title":"Malignant cells facilitate lung metastasis by bringing their own soil","volume":"107","author":"Duda","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-15-1633","article-title":"Identification of cancer-associated fibroblasts in circulating blood from patients with metastatic breast cancer","volume":"75","author":"Ao","year":"2015","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2017.03.004","article-title":"Brain metastasization of breast cancer","volume":"1868","author":"Cust\u00f3dio-Santos","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms14011383","article-title":"Role of the blood-brain barrier in the formation of brain metastases","volume":"14","author":"Wilhelm","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.34.1.207","article-title":"Fine structural localization of a blood-brain barrier to exogenous peroxidase","volume":"34","author":"Reese","year":"1967","journal-title":"J Cell Biol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"Ballabh","year":"2004","journal-title":"Neurobiol Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.2010.053132","article-title":"Bidirectional control of arteriole diameter by astrocytes","volume":"96","author":"Gordon","year":"2011","journal-title":"Exp Physiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nature09613","article-title":"Glial and neuronal control of brain blood flow","volume":"468","author":"Attwell","year":"2010","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/325253a0","article-title":"Astrocytes induce blood-brain barrier properties in endothelial cells","volume":"325","author":"Janzer","year":"1987","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1177\/1073858402008003011","article-title":"Ion regulation in the brain: implications for pathophysiology","volume":"8","author":"Somjen","year":"2002","journal-title":"Neuroscientist"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1985.65.1.101","article-title":"Effect of anoxia on ion distribution in the brain","volume":"65","author":"Hansen","year":"1985","journal-title":"Physiol Rev"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-10-1564","article-title":"Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer","volume":"16","author":"Lockman","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B52","article-title":"The blood-tissue barrier of human brain tumors: correlation of scintigraphic and ultrastructural findings: concise communication","volume":"25","author":"Front","year":"1984","journal-title":"J Nucl Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3109\/01913129709023246","article-title":"Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues","volume":"21","author":"Bertossi","year":"1997","journal-title":"Ultrastruct Pathol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.21558","article-title":"Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton","volume":"86","author":"Liu","year":"2008","journal-title":"J Neurosci Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-16-1711","article-title":"Quantitative fluorescence microscopy measures vascular pore size in primary and metastatic brain tumors","volume":"77","author":"Mittapalli","year":"2017","journal-title":"Cancer Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000236313.50833.ee","article-title":"Ratio of trastuzumab levels in serum and cerebrospinal fluid is altered in HER2-positive breast cancer patients with brain metastases and impairment of blood-brain barrier","volume":"18","author":"Stemmler","year":"2007","journal-title":"Anticancer Drugs"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24735","article-title":"Disruption of the blood brain barrier by brain metastases of triple-negative and basal-type breast cancer but not HER2\/neu-positive breast cancer","volume":"116","author":"Yonemori","year":"2010","journal-title":"Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.radonc.2017.08.006","article-title":"Blood-tumor barrier opening changes in brain metastases from pre to one-month post radiation therapy","volume":"125","author":"Teng","year":"2017","journal-title":"Radiother Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31090","article-title":"ADAM8 expression in breast cancer derived brain metastases: Functional implications on MMP-9 expression and transendothelial migration in breast cancer cells","volume":"142","author":"Conrad","year":"2018","journal-title":"Int J Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/sj.jcbfm.9600375","article-title":"Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat","volume":"27","author":"Yang","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1448089","article-title":"Lipocalin-2 promotes breast cancer brain metastasis by enhancing tumor invasion and modulating brain microenvironment","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae169","article-title":"ENPP1 induces blood-brain barrier dysfunction and promotes brain metastasis formation in human epidermal growth factor receptor 2-positive breast cancer","volume":"27","author":"Santos","year":"2025","journal-title":"Neuro Oncol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"14736","DOI":"10.1038\/s41598-025-99685-3","article-title":"GRB2 promotes brain metastasis in HER2-positive breast cancer by regulating the Ras\/MAPK pathway","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1172\/jci190470","article-title":"HIF-1 promotes murine breast cancer brain metastasis by increasing production of integrin \u03b23-containing extracellular vesicles","volume":"135","author":"Yang","year":"2025","journal-title":"J Clin Invest"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28433","article-title":"The proinflammatory peptide substance P promotes blood-brain barrier breaching by breast cancer cells through changes in microvascular endothelial cell tight junctions","volume":"134","author":"Rodriguez","year":"2014","journal-title":"Int J Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-27841-9_669-2","article-title":"Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain","volume":"232","author":"Avraham","year":"2014","journal-title":"J Pathol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noy044","article-title":"Breast cancer brain metastasis: molecular mechanisms and directions for treatment","volume":"20","author":"Pedrosa","year":"2018","journal-title":"Neuro Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.03.007","article-title":"Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis","volume":"25","author":"Zhou","year":"2014","journal-title":"Cancer Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"7461727","DOI":"10.1007\/978-3-642-27841-9_669-2","article-title":"Exosomes derived from brain metastatic breast cancer cells destroy the blood-brain barrier by carrying lncRNA GS1-600G8.5","volume":"2020","author":"Lu","year":"2020","journal-title":"BioMed Res Int"},{"key":"B70","doi-asserted-by":"publisher","first-page":"690","DOI":"10.20892\/j.issn.2095-3941.2025.0014","article-title":"Cancer cell-derived migrasomes harboring ATF6 promote breast cancer brain metastasis via endoplasmic reticulum stress-mediated disruption of the blood-brain barrier","volume":"22","author":"Wang","year":"2025","journal-title":"Cancer Biol Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nature08021","article-title":"Genes that mediate breast cancer metastasis to the brain","volume":"459","author":"Bos","year":"2009","journal-title":"Nature"},{"key":"B72","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1158\/2159-8290.cd-19-0384","article-title":"Circulating tumor cells exhibit metastatic tropism and reveal brain metastasis drivers","volume":"10","author":"Klotz","year":"2020","journal-title":"Cancer Discov"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-018-1806-2","article-title":"T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression","volume":"135","author":"Mustafa","year":"2018","journal-title":"Acta Neuropathol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28848","article-title":"Cancer-associated fibroblast promote transmigration through endothelial brain cells in three-dimensional in vitro models","volume":"135","author":"Choi","year":"2014","journal-title":"Int J Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119655","article-title":"Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation","volume":"10","author":"Krizbai","year":"2015","journal-title":"PloS One"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-10-2574","article-title":"ERK1\/2 and p38\u03b1\/\u03b2 signaling in tumor cell quiescence: opportunities to control dormant residual disease","volume":"17","author":"Sosa","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.actbio.2020.02.039","article-title":"An in vitro hyaluronic acid hydrogel based platform to model dormancy in brain metastatic breast cancer cells","volume":"107","author":"Narkhede","year":"2020","journal-title":"Acta Biomater"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3793","article-title":"Mechanisms of disseminated cancer cell dormancy: an awakening field","volume":"14","author":"Sosa","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-24-1977","article-title":"Mucin 5AC promotes breast cancer brain metastasis through cMET\/CD44v6","volume":"31","author":"Maurya","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2072","article-title":"Real-time imaging reveals the single steps of brain metastasis formation","volume":"16","author":"Kienast","year":"2010","journal-title":"Nat Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.01.040","article-title":"Serpins promote cancer cell survival and vascular co-option in brain metastasis","volume":"156","author":"Valiente","year":"2014","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005857","article-title":"The vascular basement membrane as \"soil\" in brain metastasis","volume":"4","author":"Carbonell","year":"2009","journal-title":"PloS One"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-019-0893-4","article-title":"FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis","volume":"38","author":"Cordero","year":"2019","journal-title":"Oncogene"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz198","article-title":"GRP94 promotes brain metastasis by engaging pro-survival autophagy","volume":"22","author":"Santana-Codina","year":"2020","journal-title":"Neuro Oncol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-14-2268","article-title":"Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt3075","article-title":"FAM50A drives breast cancer brain metastasis through interaction with C9ORF78 to enhance L-asparagine production","volume":"11","author":"Chen","year":"2025","journal-title":"Sci Adv"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32742","article-title":"LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer","volume":"146","author":"Blazquez","year":"2020","journal-title":"Int J Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.1038\/s41467-024-48740-0","article-title":"Breast cancer cell-secreted miR-199b-5p hijacks neurometabolic coupling to promote brain metastasis","volume":"15","author":"Ruan","year":"2024","journal-title":"Nat Commun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40779-023-00470-y","article-title":"RARRES2 regulates lipid metabolic reprogramming to mediate the development of brain metastasis in triple negative breast cancer","volume":"10","author":"Li","year":"2023","journal-title":"Mil Med Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1524-y","article-title":"Microglia-blood vessel interactions: a double-edged sword in brain pathologies","volume":"131","author":"Dudvarski Stankovic","year":"2016","journal-title":"Acta Neuropathol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1547333","article-title":"IL6\/CCL2 from M2-polarized microglia promotes breast cancer brain metastasis and the reversal effect of \u03b2-elemene","volume":"16","author":"Feng","year":"2025","journal-title":"Front Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-1102","article-title":"Loss of XIST in breast cancer activates MSN-c-Met and reprograms microglia via exosomal miRNA to promote brain metastasis","volume":"78","author":"Xing","year":"2018","journal-title":"Cancer Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-14-1226","article-title":"Role of the neural niche in brain metastatic cancer","volume":"74","author":"Termini","year":"2014","journal-title":"Cancer Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae347","article-title":"CCL2 blockade combined with PD-1\/P-selectin immunomodulators impedes breast cancer brain metastasis","volume":"148","author":"Israeli Dangoor","year":"2025","journal-title":"Brain"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.18.660428","article-title":"Soluble E-cadherin drives brain metastasis in inflammatory breast cancer","author":"Hu","year":"2025","journal-title":"bioRxiv [Preprint]"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/nature18268","article-title":"Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer","volume":"533","author":"Chen","year":"2016","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou128","article-title":"Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells","volume":"16","author":"Kim","year":"2014","journal-title":"Neuro Oncol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1593\/neo.11112","article-title":"Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy","volume":"13","author":"Kim","year":"2011","journal-title":"Neoplasia"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/nature15376","article-title":"Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth","volume":"527","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-19-0270","article-title":"Polyunsaturated fatty acids from astrocytes activate PPAR\u03b3 signaling in cancer cells to promote brain metastasis","volume":"9","author":"Zou","year":"2019","journal-title":"Cancer Discov"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01509-5","article-title":"Astrocyte-induced Cdk5 expedites breast cancer brain metastasis by suppressing MHC-I expression to evade immune recognition","volume":"26","author":"Yuzhalin","year":"2024","journal-title":"Nat Cell Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/glia.21022","article-title":"Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way","volume":"58","author":"Pukrop","year":"2010","journal-title":"Glia"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.417","article-title":"Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis","volume":"32","author":"Louie","year":"2013","journal-title":"Oncogene"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1322098111","article-title":"Human breast cancer metastases to the brain display GABAergic properties in the neural niche","volume":"111","author":"Neman","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1576-6","article-title":"Synaptic proximity enables NMDAR signalling to promote brain metastasis","volume":"573","author":"Zeng","year":"2019","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad175","article-title":"SRRM4-mediated REST to REST4 dysregulation promotes tumor growth and neural adaptation in breast cancer leading to brain metastasis","volume":"26","author":"Deshpande","year":"2024","journal-title":"Neuro Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgq269","article-title":"\u03b2-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis","volume":"32","author":"Klemm","year":"2011","journal-title":"Carcinogenesis"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-07-5644","article-title":"Subtypes of breast cancer show preferential site of relapse","volume":"68","author":"Smid","year":"2008","journal-title":"Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-07-4039","article-title":"Activation of notch signaling in a xenograft model of brain metastasis","volume":"14","author":"Nam","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201201623","article-title":"Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain","volume":"5","author":"Xing","year":"2013","journal-title":"EMBO Mol Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13058-018-1020-0","article-title":"NOTCH3 expression is linked to breast cancer seeding and distant metastasis","volume":"20","author":"Leontovich","year":"2018","journal-title":"Breast Cancer Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab159","article-title":"The PI3K\/Akt\/mTOR pathway as a preventive target in melanoma brain metastasis","volume":"24","author":"Tehranian","year":"2022","journal-title":"Neuro Oncol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/s1470-2045(20)30556-8","article-title":"The genomic landscape of breast cancer brain metastases: a systematic review","volume":"22","author":"Morgan","year":"2021","journal-title":"Lancet Oncol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/glia.23485","article-title":"PI3K: A master regulator of brain metastasis-promoting macrophages\/microglia","volume":"66","author":"Blazquez","year":"2018","journal-title":"Glia"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2011.36.1196","article-title":"PI3K\/Akt\/mTOR inhibitors in breast cancer","volume":"12","author":"Lee","year":"2015","journal-title":"Cancer Biol Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ajpath.2013.03.023","article-title":"Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases","volume":"183","author":"Hohensee","year":"2013","journal-title":"Am J Pathol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3071","article-title":"Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases","volume":"13","author":"Adamo","year":"2011","journal-title":"Breast Cancer Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3150","article-title":"Relevance of PTEN loss in brain metastasis formation in breast cancer patients","volume":"14","author":"Wikman","year":"2012","journal-title":"Breast Cancer Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-016-9649-6","article-title":"The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer","volume":"35","author":"Hsu","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-06-3316","article-title":"Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain","volume":"67","author":"Palmieri","year":"2007","journal-title":"Cancer Res"},{"key":"B122","doi-asserted-by":"publisher","first-page":"6378","DOI":"10.1016\/j.cell.2008.07.036","article-title":"FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2\/erbB2 oncogene","volume":"184","author":"Zuo","year":"2021","journal-title":"Cell"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2656","article-title":"Novel anticancer targets: revisiting ERBB2 and discovering ERBB3","volume":"9","author":"Baselga","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal4682","article-title":"The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation","volume":"9","author":"Kodack","year":"2017","journal-title":"Sci Transl Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/865819","article-title":"Regulation of SRC family kinases in human cancers","volume":"2011","author":"Sen","year":"2011","journal-title":"J Signal Transduct"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.129","article-title":"Src kinases as therapeutic targets for cancer","volume":"6","author":"Kim","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e10-09-0790","article-title":"Distinct roles for paxillin and Hic-5 in regulating breast cancer cell morphology, invasion, and metastasis","volume":"22","author":"Deakin","year":"2011","journal-title":"Mol Biol Cell"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-12","article-title":"Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion","volume":"9","author":"Sachdev","year":"2009","journal-title":"BMC Cancer"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1083\/jcb1977oia10","article-title":"VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd","volume":"209","author":"Sun","year":"2012","journal-title":"J Exp Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.01.001","article-title":"Emerging strategies for treating brain metastases from breast cancer","volume":"27","author":"Kodack","year":"2015","journal-title":"Cancer Cell"},{"key":"B131","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.03.002","article-title":"Targeting CDK4\/6 in patients with cancer","volume":"45","author":"Hamilton","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1810527","article-title":"Overall survival with palbociclib and fulvestrant in advanced breast cancer","volume":"379","author":"Turner","year":"2018","journal-title":"N Engl J Med"},{"key":"B134","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/978-3-030-23417-1_3","article-title":"Brain metastasis","volume":"20","author":"Boire","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0044-4","article-title":"STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis","volume":"24","author":"Priego","year":"2018","journal-title":"Nat Med"},{"key":"B136","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1038\/s41467-019-10493-6","article-title":"Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma","volume":"10","author":"Henrik Heiland","year":"2019","journal-title":"Nat Commun"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3389\/or.2022.10568","article-title":"NF-\u03baB signaling in tumor pathways focusing on breast and ovarian cancer","volume":"16","author":"Devanaboyina","year":"2022","journal-title":"Oncol Rev"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092587","article-title":"NF-\u03baB pathway and its inhibitors: A promising frontier in the management of alzheimer's disease","volume":"11","author":"Sivamaruthi","year":"2023","journal-title":"Biomedicines"},{"key":"B139","doi-asserted-by":"publisher","first-page":"103519","DOI":"10.2139\/ssrn.3881304","article-title":"Olfactory receptor 5B21 drives breast cancer metastasis","volume":"24","author":"Li","year":"2021","journal-title":"iScience"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9040371","article-title":"GBP5 repression suppresses the metastatic potential and PD-L1 expression in triple-negative breast cancer","volume":"9","author":"Cheng","year":"2021","journal-title":"Biomedicines"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax8933","article-title":"Connexins orchestrate progression of breast cancer metastasis to the brain by promoting FAK activation","volume":"14","author":"Lorusso","year":"2022","journal-title":"Sci Transl Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203884","article-title":"RNF126-mediated MRE11 ubiquitination activates the DNA damage response and confers resistance of triple-negative breast cancer to radiotherapy","volume":"10","author":"Liu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B143","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/nejm199002223220802","article-title":"A randomized trial of surgery in the treatment of single metastases to the brain","volume":"322","author":"Patchell","year":"1990","journal-title":"N Engl J Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2017.06.118","article-title":"Simultaneous resection of multiple metastatic brain tumors with multiple keyhole craniotomies","volume":"106","author":"Baker","year":"2017","journal-title":"World Neurosurg"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-024-04744-w","article-title":"Neurosurgical resection of multiple brain metastases: outcomes, complications, and survival rates in a retrospective analysis","volume":"169","author":"Niedermeyer","year":"2024","journal-title":"J Neuro-Oncol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3171\/2023.11.jns231923","article-title":"Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non-small cell lung cancers","volume":"141","author":"Sauvageot","year":"2024","journal-title":"J Neurosurg"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(17)30441-2","article-title":"Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial","volume":"18","author":"Brown","year":"2017","journal-title":"Lancet Oncol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: A randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"Jama"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1200\/jco.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3187","article-title":"Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy","volume":"6","author":"Zeng","year":"2015","journal-title":"Oncotarget"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3171\/2018.10.jns182340","article-title":"Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases","volume":"132","author":"Parsai","year":"2020","journal-title":"J Neurosurg"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-011432","article-title":"Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long term results and biomarker analysis from a non-randomized, open-label, phase Ib study","volume":"13","author":"Ahmed","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-06-2478","article-title":"Brain metastases: the HER2 paradigm","volume":"13","author":"Lin","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1056\/nejm200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1413513","article-title":"Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer","volume":"372","author":"Swain","year":"2015","journal-title":"N Engl J Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11436","article-title":"Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma","volume":"97","author":"Bendell","year":"2003","journal-title":"Cancer"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2003.09.018","article-title":"Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment","volume":"40","author":"Shmueli","year":"2004","journal-title":"Eur J Cancer"},{"key":"B160","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/sj.bjc.6604941","article-title":"Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients","volume":"100","author":"Park","year":"2009","journal-title":"Br J Cancer"},{"key":"B161","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/s1470-2045(12)70432-1","article-title":"Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study","volume":"14","author":"Bachelot","year":"2013","journal-title":"Lancet Oncol"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.00147","article-title":"Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with \u2265 2 HER2-directed regimens: Phase III NALA trial","volume":"38","author":"Saura","year":"2020","journal-title":"J Clin Oncol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1056\/nejmoa1914609","article-title":"Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer","volume":"382","author":"Murthy","year":"2020","journal-title":"N Engl J Med"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30256-0","article-title":"Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study","volume":"19","author":"Murthy","year":"2018","journal-title":"Lancet Oncol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu486","article-title":"Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA","volume":"26","author":"Krop","year":"2015","journal-title":"Ann Oncol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2018.07.004","article-title":"T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer","volume":"41","author":"Fabi","year":"2018","journal-title":"Breast"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01935-8","article-title":"Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial","volume":"28","author":"Bartsch","year":"2022","journal-title":"Nat Med"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03261-7","article-title":"Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b\/4 trial","volume":"30","author":"Harbeck","year":"2024","journal-title":"Nat Med"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.26","article-title":"Treating cancer with selective CDK4\/6 inhibitors","volume":"13","author":"O'Leary","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01562-9","article-title":"Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial","volume":"27","author":"Xu","year":"2021","journal-title":"Nat Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(15)00613-0","article-title":"Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial","volume":"17","author":"Cristofanilli","year":"2016","journal-title":"Lancet Oncol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1001\/jamaoncol.2019.4782","article-title":"The effect of abemaciclib plus fulvestrant on overall survival in hormone receptor-positive, ERBB2-negative breast cancer that progressed on endocrine therapy-MONARCH 2: a randomized clinical trial","volume":"6","author":"Sledge","year":"2020","journal-title":"JAMA Oncol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1911149","article-title":"Overall survival with ribociclib plus fulvestrant in advanced breast cancer","volume":"382","author":"Slamon","year":"2020","journal-title":"N Engl J Med"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-20-1764","article-title":"A phase II study of abemaciclib in patients with brain metastases secondary to hormone receptor-positive breast cancer","volume":"26","author":"Tolaney","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-15-0369","article-title":"Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets","volume":"5","author":"Brastianos","year":"2015","journal-title":"Cancer Discov"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1002\/path.4583","article-title":"Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance","volume":"237","author":"Saunus","year":"2015","journal-title":"J Pathol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noz105","article-title":"Targeting the PI3K\/Akt\/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases","volume":"21","author":"Ippen","year":"2019","journal-title":"Neuro Oncol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-18-3049","article-title":"The dual PI3K\/mTOR pathway inhibitor GDC-0084 achieves antitumor activity in PIK3CA-mutant breast cancer brain metastases","volume":"25","author":"Ippen","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B179","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/nejmoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N Engl J Med"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70138-X","article-title":"Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"15","author":"Andr\u00e9","year":"2014","journal-title":"Lancet Oncol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1177\/1758835918807339","article-title":"Phase Ib\/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09)","volume":"10","author":"Hurvitz","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy272.294","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N Engl J Med"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-8049(18)30285-5","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N Engl J Med"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(02)00615-3","article-title":"Cancer susceptibility and the functions of BRCA1 and BRCA2","volume":"108","author":"Venkitaraman","year":"2002","journal-title":"Cell"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32540","article-title":"Patterns of recurrence and metastasis in BRCA1\/BRCA2-associated breast cancers","volume":"126","author":"Song","year":"2020","journal-title":"Cancer"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi351","article-title":"Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases","volume":"16","author":"Albiges","year":"2005","journal-title":"Ann Oncol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy216","article-title":"Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors","volume":"29","author":"Diossy","year":"2018","journal-title":"Ann Oncol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065x.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1809615","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med"},{"key":"B190","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3892\/ijo_00000282","article-title":"Regulatory T cells actively infiltrate metastatic brain tumors","volume":"34","author":"Sugihara","year":"2009","journal-title":"Int J Oncol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920936151","article-title":"Emerging treatment strategies for breast cancer brain metastasis: from translational therapeutics to real-world experience","volume":"12","author":"Ren","year":"2020","journal-title":"Ther Adv Med Oncol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0918-0","article-title":"Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis","volume":"26","author":"Brastianos","year":"2020","journal-title":"Nat Med"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/s0093-7754(02)70065-1","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin Oncol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1177\/1758834016676703","article-title":"Antiangiogenic therapy for refractory colorectal cancer: current options and future strategies","volume":"9","author":"Riechelmann","year":"2017","journal-title":"Ther Adv Med Oncol"},{"key":"B195","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13058-020-01372-w","article-title":"Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases","volume":"22","author":"Leone","year":"2020","journal-title":"Breast Cancer Res"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-21-1549","article-title":"Aging and CNS myeloid cell depletion attenuate breast cancer brain metastasis","volume":"27","author":"Wu","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B197","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10585-025-10366-x","article-title":"A CSF-1R inhibitor both prevents and treats triple-negative breast cancer brain metastases in hematogenous preclinical models","volume":"42","author":"Zhang","year":"2025","journal-title":"Clin Exp Metastasis"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg8139","article-title":"The CCL2-CCR2 astrocyte cancer cell axis in tumor extravasation at the brain","volume":"7","author":"Hajal","year":"2021","journal-title":"Sci Adv"},{"key":"B199","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10585-008-9210-2","article-title":"Role of the CXCR4\/CXCL12 signaling axis in breast cancer metastasis to the brain","volume":"27","author":"Hinton","year":"2010","journal-title":"Clin Exp Metastasis"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1038\/nature15756","article-title":"Tumour exosome integrins determine organotropic metastasis","volume":"527","author":"Hoshino","year":"2015","journal-title":"Nature"},{"key":"B201","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cmet.2021.12.001","article-title":"Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness","volume":"34","author":"Parida","year":"2022","journal-title":"Cell Metab"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.00775","article-title":"Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.01511","article-title":"TBCRC 022: a phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases","volume":"37","author":"Freedman","year":"2019","journal-title":"J Clin Oncol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(17)30303-0","article-title":"Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial(\u2606)","volume":"31","author":"Montemurro","year":"2020","journal-title":"Ann Oncol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41523-024-00635-5","article-title":"Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer","volume":"10","author":"Hurvitz","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"B206","doi-asserted-by":"publisher","first-page":"8839","DOI":"10.1038\/ncomms9839","article-title":"Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma","volume":"6","author":"De Mattos-Arruda","year":"2015","journal-title":"Nat Commun"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0882-3","article-title":"Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid","volume":"565","author":"Miller","year":"2019","journal-title":"Nature"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-19-3926","article-title":"Longitudinal monitoring of ctDNA in patients with melanoma and brain metastases treated with immune checkpoint inhibitors","volume":"26","author":"Lee","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041329","article-title":"The power and promise of patient-derived xenografts of human breast cancer","volume":"14","author":"Lewis","year":"2024","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B210","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13058-024-01865-y","article-title":"Utilizing human cerebral organoids to model breast cancer brain metastasis in culture","volume":"26","author":"Wang","year":"2024","journal-title":"Breast Cancer Res"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.01.024","article-title":"In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain","volume":"273","author":"Modarres","year":"2018","journal-title":"J Control Release"},{"key":"B212","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.ccell.2025.06.019","article-title":"A stratification system for breast cancer based on basoluminal tumor cells and spatial tumor architecture","volume":"43","author":"Meyer","year":"2025","journal-title":"Cancer Cell"},{"key":"B213","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-023-01805-y","article-title":"Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer","volume":"22","author":"Ye","year":"2023","journal-title":"Mol Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801614\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:38:06Z","timestamp":1774593486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801614\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":213,"alternative-id":["10.3389\/fimmu.2026.1801614"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1801614","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1801614"}}